Published on Jul 4, 2018
pegvaliase: new drug approved in 2018

pegvaliase:

MOA:

  •  phenylalanine-metabolizing enzyme

USE:

  • to reduce blood phenylalanine concentrations in adult patients with phenylketonuria who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management


Website
Terms and Conditions Privacy Refund Policy Learning Management System by Testpress